3696 — Insilico Medicine Cayman TopCo Share News
0.000.00%
Last trade - 00:00- HK$22.88bn
- HK$18.44bn
- $56.24m
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7
InSilico Medicine climbs as chairman plans to buy shares
Brief: Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing Plan
Brief: Insilico Medicine Cayman Enters Subscription Agreement For US$305 Million Bonds On Aug 27
Brief: Insilico Medicine Cayman Topco Says No Dividends Were Paid, Declared Or Proposed During HY
Brief: InSilico Medicine Cayman TopCo Posts HY Profit Of US$35.5 MLN
Brief: Insilico Medicine Cayman Topco Says Possible Participation In Establishment Of An Investment Fund
Brief: Insilico Medicine Included In Msci Global Small Cap Indexes, Gaining Capital Market Endorsement In Core Strengths
InSilico Medicine climbs on inclusion in MSCI Global Small Cap Indexes
Brief: Insilico Medicine Cayman Topco Receives NMPA IND Approval For ISM8969/HT-001
Brief: Insilico Medicine Receives FDA Fast Track Designation For Ism6331, The Ai-Driven Pan-Tead Inhibitor, In Advanced Mesothelioma
Brief: Insilico Medicine Cayman TopCo Receives FDA Fast Track Designation For ISM6331 In Advanced Mesothelioma
Brief: Insilico Medicine Announces Oral Presentation At Esmo 2026 For Phase 1 Clinical Study Of Ism6331 In Mesothelioma And Advanced Solid Tumors
AI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine